Next-gen microwave ablation system from Microsulis is OK'ed by FDA

12/26/2012 | (Boston)

The FDA has cleared Microsulis Medical to market the Accu2i pMTA system, a next-generation device for percutaneous microwave ablation treatment. The redesigned device has ridged contact points and a design that allows the user to watch the progress of coolant through the applicator.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC